Target intelligence / Profile preview

Meis homeobox 3 (MEIS3)

Target
MEIS3
Molecular classification
Transcription factor, Homeobox protein, TALE (Three Amino acid Loop Extension) homeobox family, KN homeodomain, Homeodomain-like superfamily
01

Overview

Meis homeobox 3 (MEIS3) encodes a nuclear homeobox protein that acts as a sequence-specific transcriptional regulator, controlling the expression of genes critical for embryonic development, tissue differentiation, and cellular proliferation. MEIS3 is highly conserved and has functional orthologs across species; in mouse models, it modulates the expression of PDPK1, influencing pancreatic beta-cell survival. During development, MEIS3 is crucial for the proper migration and proliferation of neural crest cells destined for the enteric nervous system, and its loss leads to profound developmental defects, including colonic aganglionosis. MEIS3 also interacts with PBX1 and other transcription factors as part of protein complexes that precisely regulate gene expression. While not a canonical drug target, aberrations in MEIS3-regulated transcription could influence disease processes, especially developmental disorders and potentially cancer biology, although direct targeting by therapeutics is not established

Other names
Homeobox protein Meis3MRG2DKFZp547H236Meis1-related protein 2Meis1 homolog 3MEIS3MEIS3_HUMAN (UniProt)
02

Biological functions

Sequence-specific DNA bindingTranscriptional regulation (RNA polymerase II-specific)Regulation of gene expression (notably PDPK1, NDFIP1, BNIP3, CCNG1)Embryonic development (hindbrain, neural crest cell migration, enteric nervous system)Cell proliferation, migration, colonization during developmentPositive regulation of pancreatic beta-cell survival
03

Disease associations

Developmental disorders (defective neural crest migration—associated with colonic aganglionosis/Hirschsprung’s disease)Cancer biology (potential role in colon cancer therapy resistance, although not directly targeted)Epilepsy, Familial Temporal Lobe, 4Agenesis of corpus callosum (with abnormal genitalia)

Beyond the preview

Go deeper on Meis homeobox 3 (MEIS3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meis homeobox 3 (MEIS3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call